Riskpilot← Back to searchSign inGet full accessRoche Aktiebolag
ABActiveOrg 5560383100Arvid Tydéns Allé 7Wholesale of pharmaceutical and medical goods · NACE 4646Est. 193971 employees
Revenue 2024
SEK 1,3B
+12% vs 2023
EBITDA margin
2.5%
0% vs 2023
Equity ratio
40.4%
Financial strength
Net profit 2024
SEK 45,1M
+96% vs 2023
| Revenue | SEK 1,3B | +12% |
| EBITDA | SEK 33,1M | +0% |
| Net profit | SEK 45,1M | +96% |
| Total assets | SEK 635,5M | +9% |
| Equity | SEK 256,7M | +20% |
| Employees | 71 | — |
Legal name
Roche Aktiebolag
Org number
5560383100
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
2 maj 1939
Share capital
SEK 20 000 000
Employees
71 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas av en av Egermark, Mathias Emil Joerin, Isabel Marianne Youssef, Hassan Ehab Abdelmoneim i förening med Graus Lopez, Olalla Maria Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder Firman tecknas av styrelsen Firman tecknas av en av Egermark, Mathias Emil Joerin, Isabel Marianne Youssef, Hassan Ehab Abdelmoneim i förening med Grau Lopez, Olalla Maria Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget importerar, säljer och marknadsför läkemedel och andra relaterade produkter inkluderande läkemedel för klinisk prövning för bahandling och prevention av sjukdomar och för främjande av människors välbefinnande samt därmed förenlig verksamhet.
Address
Arvid Tydéns Allé 7
Phone
+4687261200
Email
roche_ab.sweden@roche.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1 233 439 | 1 100 861 | 1 112 248 | 1 200 434 | 1 347 947 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −1 426 | −16 973 | −93 937 | 33 159 | 33 070 |
| Depreciation & amort. | −1 845 | −1 681 | −1 430 | −1 402 | −1 411 |
| EBIT | −3 271 | −18 654 | −95 367 | 31 757 | 31 659 |
| Net financials | 39 738 | 38 682 | 131 162 | −2 160 | 26 297 |
| Profit before tax | 36 468 | 20 028 | 35 796 | 29 597 | 57 956 |
| Tax | −8 448 | −4 685 | −7 891 | −6 641 | −12 860 |
| Net profit | 28 020 | 15 343 | 27 905 | 22 956 | 45 096 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 512 236 | 543 881 | 421 883 | 581 948 | 635 544 |
| Equity | 147 078 | 162 421 | 190 325 | 213 281 | 256 734 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 351 519 | 377 215 | 219 186 | 366 274 | 378 810 |
| Total debt | 351 519 | 377 215 | 219 186 | 366 274 | 378 810 |
EBITDA margin
2.5%
This company
15.8%
Market median
-84% vs market
20202024
Equity ratio
40.4%
This company
38.2%
Market median
+6% vs market
20202024
Return on equity
17.6%
This company
18.4%
Market median
+4% vs market
20202024
Net profit margin
3.3%
This company
8.1%
Market median
-59% vs market
20202024
Asset turnover
2.12×
This company
1.12×
Market median
+89% vs market
20202024
Debt / equity
1.48×
This company
0.62×
Market median
-139% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
HE Chief Auditor | Chief Auditor | 2021 |
OM Chief Executive Officer | Chief Executive Officer | 2026 |
| Former (4) | ||
YN Chief Executive Officer | Chief Executive Officer | 2024 – 2025 |
KL Chief Executive Officer | Chief Executive Officer | 2022 – 2024 |
AL Chief Executive Officer | Chief Executive Officer | 2021 – 2022 |
YN Chief Executive Officer | Chief Executive Officer | 2025 – 2026 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2021 | |
| Board of Directors | 2024 | |
| Board of Directors | 2021 | |
| Former (2) | ||
| Board of Directors | 2022 – 2024 | |
| Board of Directors | 2022 – 2023 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2025 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
ROCHE HOLDING LTD
Roche Aktiebolag (this company)Board members of Roche Aktiebolag also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Yoshito Nakanishi | Chief Executive Officer | 0 companies |
| Hans Evert Blom | Chief Auditor | 0 companies |
| Olalla Maria Graus Lopez | Chief Executive Officer | 0 companies |
| Kara Lynn Brotemarkle | Chief Executive Officer | 0 companies |
| Amy Louise Van Buskirk | Chief Executive Officer | 0 companies |
| Yoshito Nakanishi | Chief Executive Officer | 0 companies |
| Per Anders Brinck | Board of Directors | 0 companies |
| Hassan Ehab Abdelmoneim Youssef | Chairman | 0 companies |
| Mathias Emil Egermark | Board of Directors | 0 companies |
| Bo Magnus Göransson | Board of Directors | 0 companies |
| Isabel Marianne Joerin | Board of Directors | 0 companies |